glp 1 drugs and vision problems Sudden loss or blurring while taking GLP-1s should be treated as a medical emergency, an expert told Newsweek GLP-1 Lawsuit Lawyer
Description
Fierce Healthcare
Access the Endocrinology Newsmakers Dashboard (Free Excel) Drugmakers work on triple agonist therapies to treat diabetes, obesity Several drugmakers are working on triple agonist therapies that target multiple receptors, such as GLP-1, GIP and glucagon (GCG)
TABLE 2 Overview of GLP-1R agonist efficacy and safety in major clinical trials
PMID: Summary Keywords biologic therapy, early psoriatic arthritis, GLP-1 receptor agonists, inflammation, metabolic syndrome, psoriasis Citation Ciancio G, Maranini B, Sandri G, Amati G, Bortoluzzi A, Silvagni E, Govoni M and Giuggioli D (2026) Glucagon-like peptide-1 receptor agonists in psoriasis and psoriatic arthritis: emerging evidence and future research opportunities
Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes
